Photo: The Theodore Roosevelt Federal Building that houses the Office of Personnel Management headquarters in Washington, D.C ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
(Distributed) Dec 23 2024 Brief amici curiae of Foreign Ends Manufacturers, et al. filed. (Distributed) Jan 10 2025 Reply of petitioners Food and Drug Administration, et al. filed. (Distributed) ...
More than 800 cases of tahini paste have been recalled due to potential salmonella contamination, with the product distributed in 19 states, Turkana Food Inc. announced Thursday. Newsweek has reached ...
Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva ...
The Food and Drug Administration has officially banned Red No. 3, an additive used for giving food and drinks a bright, cherry-red color. The FDA announced on Wednesday that it has amended its ...
The Food and Drug Administration has banned Red Dye No. 3 for its potential cancer risk, and other ingredients could be next to face the agency's scrutiny. Health advocates have long called for ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate ...
Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat ...